No Room for Germs
Supporting the Control of spread of infection and contamination
About
ZeBox™ from Biomoneta® is an air decontamination technology that works in the presence of humans to trap & kill microbes which cause disease and product contamination.
Our continuous-use, no-touch devices are built around this disruptive patent-pending technology that finds application in multiple environments requiring clean, germ-free air. ZeBox™ technology is validated by clinical partners and NABL-accredited laboratories under the aegis of FICCI.
Our continuous-use, no-touch devices are built around this disruptive patent-pending technology that finds application in multiple environments requiring clean, germ-free air. ZeBox™ technology is validated by clinical partners and NABL-accredited laboratories under the aegis of FICCI.
The problemS at Hand
- Before the COVID-19 pandemic, a WHO report estimated that nearly 10 million people will die due to resistant infections by 2050 due to a simple truth: "When bacteria change, antibiotics can stop working". A case in Nevada, U.S.A. from early 2017 only highlights this. Even preventable diseases such as pneumonia continue to claim lives globally, including in India.
- A single new virus has disrupted the whole world. An approach to infection control is now vital to the future of our way of life.
- Microbe-free clean environments are also vital to prevent business losses in the manufacturing and logistics of medical devices, biotechnology products and pharmaceuticals.
- Contaminating microbes can adversely impact the outcomes in research laboratories.
Why the ZeBOX
In the face of growing antimicrobial resistance, we need to deploy multiple strategies, including technologies that help prevent the spread of infection. Our technology has the added benefit of addressing contamination in laboratories by creating clean environments to meet industry requirements.
|
Broad spectrum
Traps & kills bacteria, viruses, fungi and spores that cause Healthcare acquired infections and spores causing the sick building syndrome. Human presence
Operates continuously and safely, achieving high efficiency in the presence of humans. |
Extreme efficiency
Within 30 minutes, traps & kills > 1 billion microbes under challenge conditions (95% reduction in the field, 9 logs in controlled tests). No toxic by-products
The device does not change the air with radiation, ionisation nor any other toxic by-products. |
Ease of use
Plug-and-play device with unique airflow design that prevents clogging and allows easy maintenance of the device. No equipment damage
Designed for intensive care environments, there is no impact on any equipment in the same room as the device. |
Safety
Type-tests certified for electrical safety under IEC 60601-1. EMI/EMC emissions are within acceptable thresholds. Zero maintenance
ZeBox™ is autonomous with only component replacements as needed. Turn it on and forget about it. |
How it works
ZeBox™ decontaminates the environment with its patent-pending technology that not only captures but also kills microbes before they can infect people or contaminate products.
|
1. ZeBox™ sucks in air from the environment where it is deployed and takes it into its capture zone.
|
2. The microbes move into the trap zone and are retained there.
|
3. The device's highly-efficient lysing mechanism disintegrates the cells, killing microbes in large numbers.
|
|
4. The cellular debris is trapped on the lysing surface as aggregates.
|
5. When the device is on, this cycle continues, maintaining a microbe-free environment.
|
6. Turning off the device leaves a clear field for the microbes to build up again.
|
It is what it is because you allowed it to be so.
suzy kassem
TEAM
Dr. Janani VenkatramanCEO
|
Arindam GhatakHead - Biological Sciences
|
Ram is the Head of Engineering at Biomoneta. Ram has been working with cutting edge technologies for over 30 years, and consults in the fields of VLSI, embedded systems and systems biology mathematical modelling. He has also been the Honorary Professor, BITS Pilani, handling IC fabrication technology, VLSI synthesis, DFT and VLSI testing and Analog IC. Previously, he was involved with Cellworks, where he led the Systems Biology computational platform, which powers Cellworks' predictive models of human bio-molecular interactions, and is used to design drugs for Cancer, Inflammation, and Infection. Ram is also specialized in Intellectual Property and served as Director, IP at Lakshmikumaran & Sridharan. Ram graduated with a Siemens Gold medal as an electrical engineer from IIT, Madras. K.S. RamanujanHead - Engineering
|
Our Ecosystem
|
|
|
|
Awards and Media
Awards and Grants
|
In the Press
|